Faculty Opinions recommendation of Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy.

2020 ◽  
Author(s):  
Cihan Yurdaydin
Keyword(s):  
Pegylated Interferon ◽  
Interferon Alfa ◽  
Hbv Infection ◽  
Safety And Efficacy ◽  
Chronic Hbv Infection ◽  
Pegylated Interferon Alfa ◽  
Chronic Hbv

Comparison of treatment efficacy with lamivudine (3TC) and interferon-alfa (IFN) in chronic HBV infection

2000 ◽  
Vol 32 ◽  
pp. 185
Author(s):  
M. Wawrzynowicz-Syczewska ◽  
W. Urbanowicz ◽  
K. Jurczyk ◽  
E. Karpińska ◽  
A. Boroń
Keyword(s):  
Treatment Efficacy ◽  
Interferon Alfa ◽  
Hbv Infection ◽  
Chronic Hbv Infection ◽  
Chronic Hbv

scholarly journals Effects of pegylated interferon-related neutropenia and thrombocytopenia on treatment of chronic HBV infection

2012 ◽  
Vol 6 (38) ◽  
pp. 6711-6719
Author(s):  
Ceylan Bahadır ◽  
Fincancı Muzaffer ◽  
Eren Guuml lhan ◽  
Muuml derrisoğlu Cuuml neyt ◽  
Soysal Ferda ◽  
...  
Keyword(s):  
Pegylated Interferon ◽  
Hbv Infection ◽  
Chronic Hbv Infection ◽  
Chronic Hbv
Sign in / Sign up

Export Citation Format

Share Document